Prevention of Capecitabine Induced Hand and Foot Syndrome
Launched by RABIN MEDICAL CENTER · Feb 7, 2011
Trial Information
Current as of June 07, 2025
Unknown status
Keywords
ClinConnect Summary
Capecitabine is a common anti cancer drug. One of the most common side effects is a syndrome called hand and foot syndrome which comprises of hands and feet redness, swelling, dryness and painful sores. Quite often the drug dose is reduced to suboptimal level due to this side effect. There is no way to prevent or an effective way to treat this side effect. Our aim is to investigate whether wearing socks which contain copper fibers may prevent or alleviate the patient symptoms.
The patients will use socks containing copper-oxide impregnated fibers which are sold in the Pharma stores without...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Clinical diagnosis of stage IV cancer - treated with Capecitabine
- Exclusion Criteria:
- • Any patient who can not sign an informed consent
- • Pregnant women
About Rabin Medical Center
Rabin Medical Center is a leading healthcare institution located in Israel, renowned for its commitment to advancing medical research and patient care. As a prominent clinical trial sponsor, the center focuses on innovative therapies and cutting-edge treatments across various disciplines, including cardiology, oncology, and neurology. With a robust infrastructure and a multidisciplinary team of experienced researchers and clinicians, Rabin Medical Center is dedicated to fostering scientific excellence and ensuring the safety and well-being of participants. The center's collaborative approach, combined with its state-of-the-art facilities, positions it at the forefront of clinical research, contributing significantly to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Petach Tikva, , Israel
Patients applied
Trial Officials
Rinat Yerushalmi, MD
Principal Investigator
Rabin Medical Center, Affiliated to Tel-Aviv University, Tel-Aviv, Israel
Aaron Sulkes, MD
Principal Investigator
Rabin Medical Center affilated to Tel-Aviv University, Tel-Aviv, Israel
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials